Dr. Stephen Hewitt is a Clinical Investigator within the Laboratory of Pathology, Center for Cancer Research, National Cancer Institute at the National Institutes of Health, Bethesda, MD. He has served as Chief of the Tissue Array Research Program since its inception in 2000, and as Chief of the Applied Molecular Pathology Laboratory since its creation in 2008.
Dr. Hewitt’s research interests are in the development of tissue based biomarkers for cancer diagnosis, prognosis and prediction of response to therapy. Specific areas of concentration include tissue microarrays, tissue proteomics, image analysis, and cancers of the aero-digestive and urogenitial tracts.
Dr. Hewitt received his bachelor’s degree in philosophy from the Johns Hopkins University in 1988, and his Ph.D. in genetics from the University of Texas, Graduate School of Biomedical Sciences in 1995, having completed his thesis in the laboratory of Grady Saunders at the University of Texas M.D. Anderson Cancer Center. He completed his M.D. in 1996 at the University of Texas Medical School at Houston, and his residency in Anatomic Pathology within the Laboratory of Pathology at the National Cancer Institute. He is a board certified Anatomic Pathologist and Fellow of the College of American Pathologist. Dr. Hewitt is co-chair of the Clinical Laboratory Standards Institute subcommittee on immunohistochemical assays and a member of the Council of the Histochemical Society. Dr Hewitt has co-authored more than 140 articles and serves on the editorial boards of three peer-reviewed Journals.
